HLTF expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.84299999945226E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.78199999995621E-07 |
Normal-vs-Stage2 |
1.362610E-03 |
Normal-vs-Stage3 |
1.85399999996783E-06 |
Normal-vs-Stage4 |
3.776100E-02 |
Stage1-vs-Stage2 |
9.182000E-01 |
Stage1-vs-Stage3 |
4.264200E-01 |
Stage1-vs-Stage4 |
8.759200E-01 |
Stage2-vs-Stage3 |
5.103000E-01 |
Stage2-vs-Stage4 |
8.327800E-01 |
Stage3-vs-Stage4 |
7.973800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.08800000015097E-07 |
Normal-vs-AfricanAmerican |
3.6840000000038E-05 |
Normal-vs-Asian |
7.293200E-01 |
Caucasian-vs-AfricanAmerican |
8.672800E-01 |
Caucasian-vs-Asian |
1.876180E-01 |
AfricanAmerican-vs-Asian |
1.960020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.21240001055889E-09 |
Normal-vs-Female |
2.378200E-01 |
Male-vs-Female |
1.988900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.0198999999943E-05 |
Normal-vs-Extreme_Weight |
8.10339999546272E-08 |
Normal-vs-Obese |
1.786390E-04 |
Normal-vs-Extreme_Obese |
7.770400E-02 |
Normal_Weight-vs-Extreme_Weight |
6.782800E-01 |
Normal_Weight-vs-Obese |
4.015200E-01 |
Normal_Weight-vs-Extreme_Obese |
6.869000E-01 |
Extreme_Weight-vs-Obese |
1.610420E-01 |
Extreme_Weight-vs-Extreme_Obese |
5.291000E-01 |
Obese-vs-Extreme_Obese |
9.373200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.578600E-01 |
Normal-vs-Age(41-60Yrs) |
1.61371999999327E-05 |
Normal-vs-Age(61-80Yrs) |
8.26360000427684E-08 |
Normal-vs-Age(81-100Yrs) |
7.60170000000393E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.998200E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.299900E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.852320E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.859800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.036800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.960000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
8.27770000322303E-08 |
Normal-VS-Type2 PRCC |
3.99540000000087E-05 |
Normal-VS-KIRP CIMP |
6.179000E-01 |
Normal-VS-Unclassified PRCC |
1.054300E-02 |
Type1 PRCC-VS-Type2 PRCC |
6.496000E-01 |
Type1 PRCC-VS-KIRP CIMP |
4.684300E-02 |
Type1 PRCC-VS-Unclassified PRCC |
2.647400E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.396790E-01 |
Type2 PRCC-VS-Unclassified PRCC |
5.438200E-01 |
KIRP CIMP-VS-Unclassified PRCC |
3.325600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.30460000025145E-07 |
Normal-vs-N1 |
1.053800E-02 |
Normal-vs-N2 |
1.914990E-01 |
N0-vs-N1 |
1.523190E-01 |
N0-vs-N2 |
7.320600E-01 |
N1-vs-N2 |
4.187600E-01 |
|
|